Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about AMYLOID: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
AMYLOID is a gene implicated in neurodegeneration research. Key relationships include: associated with, activates, inhibits. Associated with ALS, ALZHEIMER, ALZHEIMER'S. Connected to 2116 entities in the SciDEX knowledge graph.
AI-generated illustration
Regenerate portrait ↻| Gene Symbol | AMYLOID |
| Associated Diseases | Aging, Als, Alzheimer, Alzheimer Disease, ALZHEIMER'S DISEASE |
| Known Drugs/Compounds | DONANEMAB, LECANEMAB, MELATONIN, NICOTINAMIDE, RAPAMYCIN, SEMAGLUTIDE |
| Interactions | A2M, ABCA1, ABCA7, ABI3, ACE, ACETYLCHOLINE |
| KG Connections | 4782 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
subgraph Pathology["Pathology"]
AMYLOID["AMYLOID"] -->|"associated with"| MICROGLIA["MICROGLIA"]
AMYLOID["AMYLOID"] -->|"associated with"| TAU["TAU"]
AMYLOID["AMYLOID"] -->|"associated with"| BACE1["BACE1"]
AMYLOID["AMYLOID"] -->|"associated with"| AUTOPHAGY["AUTOPHAGY"]
AMYLOID["AMYLOID"] -->|"associated with"| APOPTOSIS["APOPTOSIS"]
AMYLOID["AMYLOID"] -->|"associated with"| GFAP["GFAP"]
AMYLOID["AMYLOID"] -->|"associated with"| NEURON["NEURON"]
AMYLOID["AMYLOID"] -->|"associated with"| SOD1["SOD1"]
AMYLOID["AMYLOID"] -->|"associated with"| NLRP3["NLRP3"]
AKT["AKT"] -->|"associated with"| AMYLOID["AMYLOID"]
end
subgraph Signaling["Signaling"]
OXIDATIVE_STRESS["OXIDATIVE STRESS"] -->|"activates"| AMYLOID["AMYLOID"]
ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"] -->|"activates"| AMYLOID["AMYLOID"]
ALZHEIMER["ALZHEIMER"] -->|"activates"| AMYLOID["AMYLOID"]
ALZHEIMER_S_DISEASE_1["ALZHEIMER'S DISEASE"] -.->|"inhibits"| AMYLOID["AMYLOID"]
ALZHEIMER_2["ALZHEIMER"] -.->|"inhibits"| AMYLOID["AMYLOID"]
end
style AMYLOID fill:#4a1a6b,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0,font-weight:bold
style MICROGLIA fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style TAU fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style BACE1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style AUTOPHAGY fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style APOPTOSIS fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style GFAP fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style NEURON fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style SOD1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style NLRP3 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style AKT fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style OXIDATIVE_STRESS fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style ALZHEIMER_S_DISEASE fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style ALZHEIMER fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style ALZHEIMER_S_DISEASE_1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style ALZHEIMER_2 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| PSEN2 | associated_with | gene | 1.00 |
| Alzheimer | therapeutic_target | disease | 1.00 |
| AGING | activates | gene | 1.00 |
| ALZHEIMER'S DISEASE | expressed_in | gene | 1.00 |
| Aging | therapeutic_target | disease | 1.00 |
| Dementia | causes | disease | 1.00 |
| Inflammation | associated_with | disease | 1.00 |
| APP | inhibits | gene | 1.00 |
| Inflammation | inhibits | disease | 1.00 |
| Neuroinflammation | inhibits | disease | 1.00 |
| Als | activates | disease | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| TAU | phosphorylates | gene | 1.00 |
| Inflammation | activates | disease | 1.00 |
| GFAP | biomarker_for | gene | 1.00 |
| Oxidative Stress | activates | pathway | 1.00 |
| ASTROCYTES | activates | gene | 1.00 |
| Neurodegeneration | biomarker_for | disease | 1.00 |
| NEUROINFLAMMATION | inhibits | gene | 1.00 |
| Neurodegeneration | interacts_with | disease | 1.00 |
| MICROGLIA | inhibits | gene | 1.00 |
| Autophagy | activates | pathway | 1.00 |
| NEUROINFLAMMATION | associated_with | gene | 1.00 |
| MTOR | associated_with | gene | 1.00 |
| APOE4 | activates | gene | 1.00 |
| APP | activates | gene | 1.00 |
| ALZHEIMER'S DISEASE | causes | gene | 1.00 |
| Aging | biomarker_for | disease | 1.00 |
| Neuroinflammation | biomarker_for | disease | 1.00 |
| Inflammation | biomarker_for | disease | 1.00 |
| Neurodegeneration | regulates | disease | 1.00 |
| Inflammation | interacts_with | disease | 1.00 |
| Neuroinflammation | activates | disease | 1.00 |
| TAU | inhibits | gene | 1.00 |
| ALZHEIMER'S DISEASE | regulates | gene | 1.00 |
| Alzheimer | causes | disease | 1.00 |
| AMYLOID-BETA | activates | gene | 1.00 |
| PSEN1 | associated_with | gene | 1.00 |
| NEURODEGENERATION | associated_with | gene | 1.00 |
| Aging | activates | disease | 1.00 |
| Neuroinflammation | regulates | disease | 1.00 |
| Inflammation | regulates | disease | 1.00 |
| Alzheimer | regulates | disease | 1.00 |
| TAU | activates | gene | 1.00 |
| Neurodegeneration | activates | disease | 1.00 |
| Tauopathy | activates | disease | 1.00 |
| TAU | causes | gene | 1.00 |
| TAU PATHOLOGY | associated_with | gene | 1.00 |
| Alzheimer | expressed_in | disease | 1.00 |
| Dementia | therapeutic_target | disease | 1.00 |
| Source | Relation | Type | Str |
|---|---|---|---|
| ALZHEIMER | inhibits | gene | 1.00 |
| ALZHEIMER | activates | gene | 1.00 |
| ALZHEIMER | biomarker_for | gene | 1.00 |
| APP/PS1 | activates | gene | 1.00 |
| TAU | interacts_with | gene | 1.00 |
| ALZHEIMER'S DISEASE | inhibits | gene | 1.00 |
| NEURODEGENERATIVE DISEASES | associated_with | gene | 1.00 |
| TAU | causes | gene | 1.00 |
| NEURODEGENERATIVE DISEASES | activates | gene | 1.00 |
| ALZHEIMER | expressed_in | gene | 1.00 |
| ALZHEIMER | causes | gene | 1.00 |
| NEURODEGENERATION | regulates | gene | 1.00 |
| TAU | activates | gene | 1.00 |
| INFLAMMATION | associated_with | gene | 1.00 |
| DEMENTIA | therapeutic_target | gene | 1.00 |
| AUTOPHAGY | activates | gene | 1.00 |
| ALZHEIMER | therapeutic_target | gene | 1.00 |
| INFLAMMATION | activates | gene | 1.00 |
| ALZHEIMER'S DISEASE | causes | gene | 1.00 |
| ALS | associated_with | gene | 1.00 |
| NEURODEGENERATION | therapeutic_target | gene | 1.00 |
| AMPK | associated_with | gene | 1.00 |
| NEURODEGENERATION | activates | gene | 1.00 |
| ALZHEIMER | regulates | gene | 1.00 |
| TAU | biomarker_for | gene | 1.00 |
| NEURODEGENERATION | inhibits | gene | 1.00 |
| OXIDATIVE STRESS | therapeutic_target | gene | 1.00 |
| TAU | inhibits | gene | 1.00 |
| INFLAMMATION | therapeutic_target | gene | 1.00 |
| ALZHEIMER'S DISEASE | phosphorylates | gene | 1.00 |
| OXIDATIVE STRESS | activates | gene | 1.00 |
| TAU | therapeutic_target | gene | 1.00 |
| ALZHEIMER'S DISEASE | activates | gene | 1.00 |
| NEURODEGENERATION | associated_with | gene | 1.00 |
| NEURODEGENERATIVE DISEASES | therapeutic_target | gene | 1.00 |
| TAU | regulates | gene | 1.00 |
| NEURODEGENERATION | biomarker_for | gene | 1.00 |
| ALZHEIMER | interacts_with | gene | 1.00 |
| ALZHEIMER'S DISEASE | associated_with | gene | 1.00 |
| TAU | associated_with | gene | 1.00 |
| PI3K | inhibits | gene | 1.00 |
| ALZHEIMER | associated_with | gene | 1.00 |
| INFLAMMATION | inhibits | gene | 1.00 |
| AKT | associated_with | gene | 1.00 |
| PRESENILIN | associated_with | gene | 1.00 |
| TREM2 | inhibits | gene | 1.00 |
| NEURODEGENERATION | interacts_with | gene | 1.00 |
| COMPLEMENT | activates | gene | 1.00 |
| CYTOKINES | activates | gene | 1.00 |
| APOPTOSIS | activates | gene | 1.00 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| TREM2 KO amyloid pathology study | validation | Alzheimers Disease | 0.800 | 0.00 | Mouse (5xFAD/TREM2-/-) | completed | N/A |
| Closed-loop tFUS Enhances Glymphatic Clearance and Restores CA1 PV Int | in_vivo | Alzheimer's disease | 0.765 | 0.55 | APP/PS1 mice 8-11 months (n=10 | proposed | $125,000 |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2- [PMID:31932797] | Zhou Y, Song WM, Andhey PS, Swain A, Lev | Nat Med | 2020 | 1 |
| Integrative Multiomics Insights into the Genetic and Epigenetic Architecture of [PMID:41422555] | Mishra AK, Jain S | ACS Chem Neurosci | 2026 | 0 |
| The association of Alzheimer's disease-related SNPs with mild cognitive impairme [PMID:41606232] | Xie Z, Tu W, Ye XF, Hua L, Zhang X et al | Sci Rep | 2026 | 0 |
| Genetic risk factors of late-onset Alzheimer's disease: Insights into pathophysi [PMID:41622452] | Akkaoui J, Devadoss D, Rodriguez MD, Ari | Neural Regen Res | 2026 | 0 |
| Genetic Burden and <i>APOE</i> Methylation in a Korean Multi-Generational Alzhei [PMID:41745359] | Eom Je-Hyun; Cho Mu-Yeol; Kim Ji-Won; Ki | Journal of personalized medici | 2026 | 0 |
| Genetic Architecture of Cognitive Resilience in Alzheimer's Disease: Mechanisms, [PMID:41893052] | Burdman Gabriel; Akkaoui Juliet; Colon N | Neurology international | 2026 | 0 |
| Posttraumatic stress disorder is associated with Alzheimer's disease-relevant mo [PMID:41960318] | Seijo MA, Yohannes PA, Rogers AL, Gonzal | Res Sq | 2026 | 0 |
| Genetic risk factors of late-onset Alzheimer's disease: Insights into pathophysi [PMID:41622452] | Akkaoui J, Devadoss D, Rodriguez MD, Ari | Neural regeneration research | 2026 | 0 |
| Genetic Architecture of Cognitive Resilience in Alzheimer's Disease: Mechanisms, [PMID:41893052] | ["Burdman G", "Akkaoui J", "Colon N", "P | Neurology international | 2026 | 0 |
| Retinal Müller glia alterations and their impact on ocular glymphatic clearance [PMID:41603340] | Das G, Raghunathan R, Wang L | J Alzheimers Dis | 2026 | 0 |
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| The Glymphatic-Venous Axis in Brain Clearance Failure: Aquaporin-4 Dysfunction, [PMID:41226584] | ["Costea D", "Dobrin N", "Tataru C", "To | International journal of molec | 2025 | 0 |
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| Longitudinal changes of blood-brain barrier and transcytolemmal water exchange p [PMID:40089221] | Xiong C, Yu Z, Yin Y | Neuroimage | 2025 | 0 |
| The future of biomarkers for vascular contributions to cognitive impairment and [PMID:40542975] | Lennon MJ, Karvelas N, Ganesh A | Geroscience | 2025 | 0 |
| P-tau217 correlates with neurodegeneration in Alzheimer's disease, and targeting [PMID:38513667] | Zhang D, Zhang W, Ming C, Gao X, Yuan H, | Neuron | 2024 | 0 |
| The necroptosis cell death pathway drives neurodegeneration in Alzheimer's disea [PMID:38852117] | Balusu S, De Strooper B | Acta neuropathologica | 2024 | 0 |
| α7nAChR activation in AT2 cells promotes alveolar regeneration through WNT7B sig [PMID:37410546] | Unknown | JCI Insight | 2023 | 0 |
| Oxidized phosphatidylcholines found in multiple sclerosis lesions mediate neurod [PMID:33603230] | Dong Y, D'Mello C, Pinsky W, Lozinski BM | Nature neuroscience | 2021 | 0 |
| Insulin Resistance and Diabetes Mellitus in Alzheimer's Disease. [PMID:34069890] | Burillo J, Marqués P, Jiménez B, Gonzále | Cells | 2021 | 0 |
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning AMYLOID in their description or question text
Score: 0.785 · unknown disease · 2026-04-12
## Mechanistic Overview Vicious Cycle Hypothesis: Cholinergic Dysfunction Exacerbates Amyloid Pathology starts from the
Score: 0.769 · unknown disease · 2026-04-12
## Mechanistic Overview Direct Toxicity Hypothesis: β-Amyloid Directly Impairs Cholinergic Signaling starts from the cla
Score: 0.755 · unknown disease · 2026-04-17
## Mechanistic Overview Test: TREM2 enhances amyloid clearance starts from the claim that modulating not yet specified w
Score: 0.740 · protein biochemistry · 2026-04-21
## **Molecular Mechanism and Rationale** The recognition of amyloidogenic protein species by the heat shock protein 70
Score: 0.735 · Alzheimer's disease · 2026-04-04
## Mechanistic Overview Stage-Specific TREM2 Biomarker-Guided Switching — Agonist in Amyloid Phase, Antagonist in Tau Ph
Score: 0.720 · neurodegeneration · 2026-04-22
**Molecular Mechanism and Rationale** The molecular basis of this hypothesis centers on the structural and biochemical
Score: 0.712 · unknown disease · 2026-04-17
## Mechanistic Overview Test: TREM2 enhances amyloid clearance starts from the claim that modulating not yet specified w
Score: 0.705 · unknown disease · 2026-04-04
**Background and Rationale** Test: TREM2 enhances amyloid clearance is a mechanistic proposition centered on the idea t
Score: 0.686 · neurodegeneration · 2026-04-26
Chronic orexin-A elevation may aggravate AD by extending wakefulness, fragmenting circadian rhythms, and increasing acti
Score: 0.680 · neurodegeneration · 2026-04-26
TREM2 agonistic antibodies restore microglial phagocytosis and plaque compaction in Alzheimer's disease, particularly fo
Score: 0.655 · unknown disease · 2026-04-17
**Molecular Mechanism and Rationale** TREM2 (Triggering Receptor Expressed on Myeloid cells 2) represents a critical mi
Score: 0.640 · neurodegeneration · 2026-04-25
Soluble Aβ oligomers trigger endothelin-1 and ROS-dependent pericyte contractile stress, and repeated exposure converts
Score: 0.637 · Alzheimer's disease · 2026-04-04
## Mechanistic Overview Stage-Selective TREM2 Agonism — Boosting DAM Phagocytosis in Early Amyloid Phase starts from the
Score: 0.637 · unknown disease · 2026-04-17
**Molecular Mechanism and Rationale** TREM2 (Triggering Receptor Expressed on Myeloid cells 2) functions as a critical
Score: 0.630 · neurodegeneration · 2026-04-25
Selective induction of a senescence program in adult pericytes is sufficient to impair barrier-supportive trophic signal